Vitamin E for the treatment of diseases in which the binding of the transcription factor NF-KB and/or AP-1 to promoter target sites has a beneficial effect (eg AIDS, cardiac infarction)

摘要

Described is the use of vitamin E for the preparation of a pharmaceutical composition for the prevention or therapy of a disease in which inhibiting or reducing the binding of the transcription factor NF-KB and/or AP-1 to promoter target sites has a beneficial effect. A preferred use is the treatment of a disease associated with T cell depletion